Diagonal Therapeutics
Cambridge, United States· Est.
Diagonal Therapeutics is discovering and developing agonist antibodies that activate receptor complexes to treat serious diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $253M
About
Diagonal Therapeutics is discovering and developing agonist antibodies that activate receptor complexes to treat serious diseases.
AntibodiesImmunologyCardiovascular
Funding History
2Total raised:$253M
PIPE$125M
PIPE$128M